Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 9, 2012, Pages

  Wong, Banny S ^a   Camilleri, Michael ^a   Carlson, Paula ^a   McKinzie, Sanna ^a   Busciglio, Irene ^a   Bondar, Olga ^b   Dyer, Roy B ^b   Lamsam, Jesse ^b   Zinsmeister, Alan R ^b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b Mayo Clinic   (United States)

Author keywords

Colon; Liver; Malabsorption; Metabolism

Indexed keywords

7ALPHA HYDROXYCHOLEST 4 EN 3 ONE; BILE ACID; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; BILE ACID SYNTHESIS; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIARRHEA; DNA POLYMORPHISM; DOWN REGULATION; FECES ANALYSIS; GENE; GENETIC ASSOCIATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; IRRITABLE COLON; KLOTHO BETA GENE; LIPID DIET; MALABSORPTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 84865313567     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.05.006     Document Type: Article

References (31)

1. Drossman D.A., Camilleri M., Mayer E.A., et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123:2108-2131.
2. Eusufzai S. Bile acid malabsorption in patients with chronic diarrhoea. Scand J Gastroenterol 1993, 28:865-868.
3. Fernández-Bañares F., Esteve M., Salas A., et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol 2007, 102:2520-2528.
4. Sciarretta G., Furno A., Morrone B., et al. Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study. Am J Gastroenterol 1994, 89:1058-1061.
5. Wedlake L., A'Hern R., Russell D., et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009, 30:707-717.
6. Wildt S., Nørby Rasmussen S., Lysgård Madsen J., et al. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scand J Gastroenterol 2003, 38:826-830.
7. Zieve F.J., Kalin M.F., Schwartz S.L., et al. Results of the glucose-lowering effect of Welchol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin Ther 2007, 29:74-83.
8. Odunsi-Shiyanbade S.T., Camilleri M., McKinzie S., et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2010, 8:159-165.
9. Chiang J.Y. Bile acids: regulation of synthesis. J Lipid Res 2009, 50:1955-1966.
10. Walters J.R., Tasleem A.M., Omer O.S., et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009, 7:1189-1194.
11. Oelkers P., Kirby L.C., Heubi J.E., et al. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest 1997, 99:1880-1887.
12. Montagnani M., Love M.W., Rössel P., et al. Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption. Scand J Gastroenterol 2001, 36:1077-1080.
13. Wong B.S., Camilleri M., McKinzie S., et al. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol 2011, 106:2154-2164.
14. Chey W.D., Camilleri M., Chang L., et al. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol 2011, 106:1803-1812.
15. Wong B.S., Camilleri M., Carlson P.J., et al. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology 2011, 140:1934-1942.
16. Rao A.S., Wong B.S., Camilleri M., et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology 2010, 139:1549-1558.
17. Wong B.S., Camilleri M., Carlson P.J., et al. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci 2012, 57:1222-1226.
18. Camilleri M., Nadeau A., Tremaine W.J., et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009, 21. 734-e43.
19. Hofmann A.F., Loening-Baucke V., Lavine J.E., et al. Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients. J Pediatr Gastroenterol Nutr 2008, 47:598-606.
20. Thomas L.A., Veysey M.J., Murphy G.M., et al. Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly. Gut 2005, 54:630-635.
21. Axelson M., Mörk B., Sjövall J. Ethanol has an acute effect on bile acid biosynthesis in man. FEBS Lett 1991, 281:155-159.
22. Brydon W.G., Nyhlin H., Eastwood M.A., et al. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol 1996, 8:117-123.
23. Duane W.C. Abnormal bile acid absorption in familial hypertriglyceridemia. J Lipid Res 1995, 36:96-107.
24. Abrahamsson H., Ostlund-Lindqvist A.M., Nilsson R., et al. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol 2008, 43:1483-1488.
25. Poley J.R., Hofmann A.F. Role of fat maldigestion in pathogenesis of steatorrhea in ileal resection. Fat digestion after two sequential test meals with and without cholestyramine. Gastroenterology 1976, 71:38-44.
26. Ung K.A., Kilander A.F., Lindgren A., et al. Impact of bile acid malabsorption on steatorrhoea and symptoms in patients with chronic diarrhoea. Eur J Gastroenterol Hepatol 2000, 12:541-547.
27. Delgado-Aros S., Camilleri M., Garcia M.A., et al. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol 2008, 295:G382-G388.
28. Sadik R., Abrahamsson H., Ung K.A., et al. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol 2004, 99:711-718.
29. Hofmann A.F., Poley J.R. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969, 281:397-402.
30. Sciarretta G., Fagioli G., Furno A., et al. 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 1987, 28:970-975.
31. Wedlake L., Thomas K., Lalji A., et al. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Clin Ther 2009, 31:2549-2558.